OGC
GILD icon

One68 Global Capital’s Gilead Sciences GILD Stock Holding History

One68 Global Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$408K Sell
7,000
-3,000
-30% -$181K 0.82% 30
2020
Q3 		$632K Buy
+10,000
New +$693K 1.68% 16

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

One68 Global Capital's GILD Position: Q4 2020 in Review

One68 Global Capital reduced its Gilead Sciences (GILD) stake by 30% in Q4 2020, selling an estimated $181K and leaving 7,000 shares worth $408K. The position accounts for 0.82% of the portfolio, ranked #30.

One68 Global Capital first reported a position in GILD in Q3 2020 and has held it in 2 quarters since. The position peaked at $632K in Q3 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • One68 Global Capital held 7,000 shares of Gilead Sciences worth $408K as of Q4 2020.
  • One68 Global Capital sold 3,000 Gilead Sciences shares in Q4 2020, an estimated $181K.
  • Gilead Sciences made up 0.82% of One68 Global Capital's portfolio in Q4 2020, its #30 holding.
  • One68 Global Capital first reported a position in Gilead Sciences in Q3 2020 and has held it in 2 quarters since.
  • One68 Global Capital's Gilead Sciences position peaked at $632K in Q3 2020.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on One68 Global Capital's 13F filing for Q4 2020, filed 16 Feb 2021.